Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–12 of 12 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT05909059
- Conditions
- Acute Lymphoblastic Leukemia, Adult, Blood Protein Disorders, Cardiovascular Diseases, +18 more
- Locations
-
- Caitlin Guzowski Atlanta, Georgia, United States
Recruiting
SynKIR-310 for Relapsed/Refractory B-NHL
NCT06544265
- Conditions
- Aggressive B-Cell Non-Hodgkin Lymphoma, B Cell Lymphoma, Blood Protein Disorders, +54 more
- Locations
-
- Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute Denver, Colorado, United States
- Winship Cancer Institute of Emory University Atlanta, Georgia, United States
- The University of Kansas Cancer Center Fairway, Kansas, United States
- Rutgers Cancer Institute New Brunswick, New Jersey, United States
NCT06156774
- Conditions
- Atrophy, Muscular Atrophy, Nervous System Diseases, +7 more
- Locations
-
- A.O. SS. Antonio e Biagio e Cesare Arrigo - S.C.D.U. Ematologia Alessandria, Italy
- AOU Ospedali Riuniti - Clinica di Ematologia Ancona, Italy
- Azienda Ospedaliera S .Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico Avellino, Italy
- IRCCS Centro di Riferimento Oncologico di Aviano - Divisione di Oncologia e dei Tumori immuto-correlati Aviano, Italy
Recruiting
Universal CAR-T Cell Therapy for NHL
NCT07248163
- Conditions
- Non-hodgkin Lymphoma,B Cell
- Locations
-
- Shanghi Tongji Hospital (Tongji Hospital of Tongji University) Shanghai, China
Recruiting
The Safety and Efficacy of BRL-201 in the Treatment of r/r B Lymphocyte Non-Hodgkin Lymphoma
NCT05741359
- Conditions
- Non-hodgkin Lymphoma,B Cell
- Locations
-
- Wuhan Union Hospital Wuhan, Hubei, China
- Tianjin Institute of Hematology Tianjin, Tianjin Municipality, China
- The First Affiliated Hospital of Zhejiang University Hangzhou, Zhejiang, China
NCT06838832
- Conditions
- Disease Attributes, Non-hodgkin Lymphoma,B Cell, Pathologic Processes, +2 more
- Locations
-
- Biotherapeutic Department of Chinsese PLA Gereral Hospital Beijing, Beijing Municipality, China
NCT06716164
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- The first affiliated hospital of medical college of zhejiang university Hangzhou, Zhejiang, China
Recruiting
CD19-BAFF CAR-T Cells Therapy for Patients With Relapsed / Refractory B-cell ALL and B-cell NHL
NCT06346912
- Conditions
- Acute Lymphoblastic Leukemia,B-Cell, Non-hodgkin Lymphoma,B Cell
- Locations
-
- The first affiliated hospital of medical college of zhejiang university Hangzhou, Zhejiang, China
NCT06321289
- Conditions
- Non-hodgkin Lymphoma,B Cell
- Locations
-
- Biotherapeutic Department of Chinese PLA General Hospital Beijing, Beijing Municipality, China
- School of medicine, Tsinghua University & Changping Laboratory Beijing, China
NCT05518383
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Diffuse Large B-cell Lymphoma, +19 more
- Locations
-
- Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology and Immunology Moscow, RF, Russia
NCT04532268
- Conditions
- Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- The First Affiliated Hospital，College of Medicine, Zhejiang University Hangzhou, Zhejiang, China
Completed
Acalabrutinib With Rituximab and Lenalidomide in Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
NCT04094142
- Conditions
- Non-hodgkin Lymphoma,B Cell
- Locations
-
- Seoul National University Hospital Seoul, South Korea